tiprankstipranks
Trending News
More News >
Bioharvest Sciences, Inc. (BHST)
:BHST
US Market
Advertisement

BioHarvest Sciences (BHST) Earnings Dates, Call Summary & Reports

Compare
41 Followers

Earnings Data

Report Date
Apr 23, 2026
TBA (Not Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
Last Year’s EPS
-0.13
Same Quarter Last Year
Based on 3 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 13, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth, particularly in the CDMO segment, and successful capital raising efforts that fortified the company's balance sheet. However, challenges remain with ongoing net losses and increased operating expenses. The sentiment is balanced due to significant achievements and challenges.
Company Guidance
In the third quarter of 2025, BioHarvest Sciences reported a 39% year-over-year revenue increase to $9.1 million, aligning with its guidance, and approached its goal of achieving adjusted EBITDA breakeven. The company's U.S. VINIA active user base surpassed 75,000, contributing to a 30% growth in the products division. Core VINIA capsules accounted for 88% of product revenues, with new products like VINIA 2X Formula Chews driving approximately 30% of growth. The CDMO business, significantly bolstered by a new partnership with Saffron Tech, represented about 25% of the quarterly revenue growth. Gross profit margins increased to 61%, reflecting benefits from scale, while total operating expenses rose slightly to $6.5 million due to increased marketing and CDMO division expenses. BioHarvest also strengthened its balance sheet, securing a $19.9 million institutional equity financing, positioning the company to expand its direct-to-consumer and CDMO operations. Looking ahead, the company anticipates fourth-quarter revenues between $9 million and $9.5 million, with adjusted EBITDA nearing breakeven.
Significant Revenue Growth
Total revenues increased 39% year-over-year to $9.1 million, driven by sustained momentum in core VINIA capsules and the expanding success of the VINIA Inside product portfolio.
CDMO Business Expansion
CDMO revenue grew 722% to $0.7 million. A new partnership with Saffron Tech was secured to develop saffron-derived compounds, with BioHarvest retaining 25% ownership.
Successful Capital Raise
Completed a $19.9 million institutional equity financing, bringing total gross proceeds from recent efforts to $30.8 million, strengthening the balance sheet.
Gross Profit Margin Improvement
Gross profit increased 50% to $5.6 million, with gross margins rising to 61% due to increased manufacturing scale and improved yields.
VINIA BloodFlow Hydration Launch
Launched an early access rollout of VINIA BloodFlow Hydration, aimed at entering the $17 billion U.S. electrolyte hydration market.

BioHarvest Sciences (BHST) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BHST Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 23, 2026
2025 (Q4)
- / -
-0.13
Nov 13, 2025
2025 (Q3)
-0.12 / -0.14
-0.1612.50% (+0.02)
Aug 11, 2025
2025 (Q2)
-0.11 / -0.24
-0.04-500.00% (-0.20)
May 15, 2025
2025 (Q1)
- / -0.13
-0.4872.92% (+0.35)
Mar 31, 2025
2024 (Q4)
-0.12 / -0.13
-0.4872.92% (+0.35)
Nov 25, 2024
2024 (Q3)
-0.05 / -0.16
-0.129-24.03% (-0.03)
Aug 29, 2024
2024 (Q2)
-0.10 / -0.04
-0.21281.13% (+0.17)
May 30, 2024
2024 (Q1)
- / -
-0.056
Apr 30, 2024
2023 (Q4)
- / -0.48
-0.056-757.14% (-0.42)
Nov 29, 2023
2023 (Q3)
- / -0.13
-0.357.00% (+0.17)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

BHST Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 13, 2025
$7.30$7.23-0.96%
Aug 11, 2025
$8.76$8.82+0.68%
May 15, 2025
$6.43$6.50+1.09%
Mar 31, 2025
$6.19$6.49+4.85%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Bioharvest Sciences, Inc. (BHST) report earnings?
Bioharvest Sciences, Inc. (BHST) is schdueled to report earning on Apr 23, 2026, TBA (Not Confirmed).
    What is Bioharvest Sciences, Inc. (BHST) earnings time?
    Bioharvest Sciences, Inc. (BHST) earnings time is at Apr 23, 2026, TBA (Not Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BHST EPS forecast?
          Currently, no data Available
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis